Category: Press release
MSF Responds to EMA approval of new tuberculosis drug delamanid
Gilead attempt to secure patent on hepatitis C drug opposed in India
MSF Responds to EMA approval of new tuberculosis drug delamanid
TB: First new tuberculosis drug in fifty years risks being squandered without better research and pricing strategies
Global Vaccine Community Must Make Major Changes to Reach More Children
Doctors Without Borders Cycle Tour Comes to Delhi
Syria: Civilians forced to flee Al Safira under heavy bombardment
WHO TB report: "An indictment of the global failure to tackle DR-TB"
CAR: Tens of Thousands Flee Attacks and Killings
